补阳还五汤加减治疗肾病综合征的疗效及临床价值

doi:10.3969/j.issn.1000-8535.2022.02.011

摘要/Abstract

摘要： 目的分析补阳还五汤加减治疗肾病综合征(NS)的临床疗效。方法选择本院2019年1月—2021年1月住院治疗的120例NS患者,通过随机数字表法分组,参照组60例患者采纳常规西医治疗,试验组60例患者在参照组基础上予以补阳还五汤治疗,对比2组临床疗效、中医症候积分、肾功能指标、不良反应总发生率。结果试验组临床总有效率(96.67%)高于参照组(80.00%),试验组治疗后浮肿少尿、腰膝酸软、腹部胀满、头晕乏力积分均低于参照组,差异均有统计学意义(P＜0.05)。治疗后试验组24 h尿蛋白、尿素氮均比参照组低,差异有统计学意义P＜0.05,血肌酐治疗前后差异无统计学意义P>0.05。试验组不良反应总发生率(5.00%)与参照组(6.67%)比较,差异无统计学意义(P>0.05)。结论补阳还五汤可有效改善NS患者临床症状、肾功能,降低蛋白尿,且不良反应较少,安全性较高,疗效确切。

关键词: 补阳还五汤, 肾病综合征, 临床疗效, 肾功能

Abstract: Objective To analyze the clinical effect of addition or reduction of Buyang Huanwu decoction in the treatment of nephrotic syndrome (NS). Methods A total of 120 NS patients in our hospital from January 2019 to January 2021 were divided into two groups by random digital table method. Sixty patients in the control group were treated by conventional western medicine, 60 patients in the experimental group were treated with Buyang Huanwu decoction on the basis of control group.The clinical efficacy, traditional Chinese medicine syndrome score, renal function index and total incidence of adverse reactions were compared. Results The total clinical effective rate of the experimental group (96.67%) was higher than that of the control group (80.00%). The scores of edema and oliguria, lumbar and knee pain and limpness, abdominal distention and dizziness after treatment in the experimental group were all lower than those in the control group, with statistical significance (P<0.05). After treatment, 24 h urinary protein volume and blood urea nitrogen level in the experimental group were lower than those in the control group, the differences were statistically significant (P<0.05), while there was no statistically significant difference in serum creatinine before and after treatment (P>0.05). There was no significant difference in the total incidence of adverse reactions between the experimental group (5.00%) and the control group (6.67%,P>0.05). Conclusion Buyang Huanwu decoction could effectively improve the clinical symptoms and renal function, reduce proteinuria, and had less adverse reactions, high safety level and accurate curative effect.

Key words: Buyang Huanwu decoction, nephrotic syndrome, clinical effect, renal function

李俊. 补阳还五汤加减治疗肾病综合征的疗效及临床价值[J]. 广州医药, 2022, 53(2): 48-51.

LI Jun. The curative effect and clinical value of the nephrotic syndrome treatment with the addition or reduction of Buyang Huanwu decoction[J]. Guangzhou Medical Journal, 2022, 53(2): 48-51.

参考文献

[1] 冯锦, 张瑛.真武汤合保元汤辅助西药治疗2型心肾综合征疗效及对ET-1、NO、炎性细胞因子水平的影响[J].中国中医急症, 2019, 28(1):125-128.
[2] 郑栓, 郑建国, 王东海, 等.益气温阳补肾汤联合西药治疗肾病综合征效果观察及对血清IL-8,IL-13及免疫功能的影响[J].陕西中医, 2017, 12(38):42-45.
[3] 郑静, 刘旭阳.参苓消肿汤联合序贯透析治疗肾病综合征顽固性水肿患者的疗效及其对血清中IL-6、IL-17及TNF-α表达的影响[J].中国中西医结合肾病杂志, 2018, 19(4):339-341.
[4] 中华医学会老年医学分会肾病学组, 国家老年疾病临床医学研究中心.老年人慢性肾脏病诊治中国专家共识(2018)[J].中华老年医学杂志, 2018, 37(7): 725-731.
[5] 张雪丽, 刘翠华, 厉洪江, 等.桂枝茯苓汤联合激素治疗小儿原发性肾病综合征疗效及对患者血清炎性因子的影响[J].陕西中医, 2018, 39(11):123-126.
[6] 蒋玉红, 卢岚, 马嘉黛, 等.禾肾丸联合加味防己黄芪汤治疗肾病综合征疗效及对血清IL-8和IL-13的影响研究[J].现代中西医结合杂志, 2017, 26(10):82-84.
[7] 郑栓, 郑建国, 王东海.益气温阳补肾汤联合西药治疗肾病综合征效果观察及对血清IL-8,IL-13及免疫功能的影响[J].陕西中医, 2017, 38(12):1664-1667.
[8] 孙宏.益气养阴活血汤联合西药治疗对血瘀型肾病综合征患者中医证候积分、肾功能及血清TIMP-2、hs-CRP水平的影响[J].四川中医, 2018, 36(8):113-115.
[9] 王文娟, 蒋霞.舒肝愈肾汤联合泼尼松治疗肾病综合征疗效及对甲状腺激素、尿蛋白和氧化应激指标的影响[J].现代中西医结合杂志, 2018, 27(29):73-76.
[10] 柴梅, 姚耀, 曹玉鹃,等.真武汤合防己茯苓汤加减联合腹水超滤浓缩回输治疗肝肾综合征顽固性腹水临床研究[J].辽宁中医药大学学报, 2019, 21(9):194-197.
[11] 龚家川.环磷酰胺、雷公藤总甙及吗替麦考酚酯三联疗法对膜性肾病患者的疗效及免疫球蛋白A、M、G水平的影响[J].中国临床医生杂志, 2018, 46(6): 689-691.
[12] 刘茜, 孙涛, 刘彬.参苓白术散加减辅助治疗难治性肾病综合征脾肾阳虚证疗效及对血清SAA和IL-6水平影响[J].辽宁中医药大学学报, 2019, 21(5): 193-196.
[13] 王莉, 金明, 黄俊波, 等.他克莫司联合糖皮质激素对难治性肾病综合征患者肝肾功能,糖脂代谢及不良反应的影响[J].解放军医药杂志, 2019, 31(2):96-99.
[14] 段学峰, 王双珠, 叶华茂,等.黄芪仙灵脾汤联合活血通脉片对肾病综合征高凝血症患者CRP和TNF-α及血液流变学的影响[J].中华全科医学, 2018, 16(7): 83-86.
[15] 姚耀, 柴梅, 曹玉鹃, 等.自拟温阳消饮汤对脾肾阳虚证肝硬化合并肝肾综合征患者肝肾功能保护、血流动力学指标及外周血肿瘤坏死因子-α、一氧化氮、可溶性细胞黏附因子-1的影响[J].世界中医药,2019,14(7):1748-1752.